Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
Bluebird Bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript Summary
Bluebird Bio Slips as 2024 Guidance Underwhelms
Earnings Summary: Bluebird Bio Beats Q2 Revenue Estimates
Here's the Major Earnings Before the Open Tomorrow
Bluebird Bio Q2 2023 Earnings Preview